U.S. Markets close in 3 hrs 44 mins

Biotest Aktiengesellschaft (BIO.DE)

XETRA - XETRA Delayed Price. Currency in EUR
Add to watchlist
41.70-0.20 (-0.48%)
At close: 05:36PM CEST
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in EUR

Valuation Measures4

Yahoo Finance Plus required to access annual data
Yahoo Finance Plus required to access monthly data
Subscribe to Yahoo Finance Plus Essential to download historical data
We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) 0.51
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 344.60
52 Week Low 328.30
50-Day Moving Average 342.21
200-Day Moving Average 341.89

Share Statistics

Avg Vol (3 month) 3309
Avg Vol (10 day) 3113
Shares Outstanding 519.79M
Implied Shares Outstanding 6N/A
Float 820.32M
% Held by Insiders 189.88%
% Held by Institutions 11.07%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.04
Trailing Annual Dividend Yield 30.10%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4May 08, 2019
Last Split Factor 23:1
Last Split Date 3Jul 15, 2015

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2021
Most Recent Quarter (mrq)Dec 31, 2021


Profit Margin -12.30%
Operating Margin (ttm)-9.87%

Management Effectiveness

Return on Assets (ttm)-2.85%
Return on Equity (ttm)-15.43%

Income Statement

Revenue (ttm)515.6M
Revenue Per Share (ttm)13.03
Quarterly Revenue Growth (yoy)1.10%
Gross Profit (ttm)80.7M
Net Income Avi to Common (ttm)-63.4M
Diluted EPS (ttm)-0.72
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)113.1M
Total Cash Per Share (mrq)2.86
Total Debt (mrq)531.2M
Total Debt/Equity (mrq)139.64
Current Ratio (mrq)4.91
Book Value Per Share (mrq)10.61

Cash Flow Statement

Operating Cash Flow (ttm)33.9M
Levered Free Cash Flow (ttm)28.64M